Wells Fargo
ENZY

Wells Fargo’s Enzymotec Ltd ENZY Stock Holding History

Wells Fargo’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,790
Closed -$33K – 6782
2017
Q4 		$33K Buy
+2,790
New +$32.4K ﹤0.01% 5673
2016
Q1 		– Sell
-31,145
Closed -$305K – 6608
2015
Q4 		$305K Buy
+31,145
New +$295K ﹤0.01% 4203
2015
Q2 		– Sell
-100
Closed -$1K – 6644
2015
Q1 		$1K Hold
100
– – ﹤0.01% 6103
2014
Q4 		$1K Sell
100
-75
-43% -$545 ﹤0.01% 6138
2014
Q3 		$2K Sell
175
-1,852
-91% -$20K ﹤0.01% 6026
2014
Q2 		$27K Sell
2,027
-9,314
-82% -$156K ﹤0.01% 5243
2014
Q1 		$250K Buy
11,341
+10,151
+853% +$269K ﹤0.01% 4234
2013
Q4 		$32K Buy
+1,190
New +$28.3K ﹤0.01% 4873

Wells Fargo's ENZY Position: Q1 2018 in Review

Wells Fargo sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 2,790 shares — an estimated $33K sold.

Wells Fargo first reported a position in ENZY in Q4 2013 and held it in 8 quarters. The position peaked at $305K in Q4 2015. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

  • Wells Fargo reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
  • Wells Fargo sold 2,790 Enzymotec Ltd shares in Q1 2018, an estimated $33K.
  • Wells Fargo first reported a position in Enzymotec Ltd in Q4 2013 and held it in 8 quarters.
  • Wells Fargo's Enzymotec Ltd position peaked at $305K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on Wells Fargo's 13F filing for Q1 2018, filed 2 May 2018.